Pancreatic Cancer Research

ResearcherNational Research CouncilActive in the last 2 years

Gabriella Minchiotti

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0225-9043; OpenAlex author ID A5045965755. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2024: 1 paper · 2025: 1 paper · 2026: 1 paper

Papers 3

  1. Mechanobiology-guided drug repurposing identifies budesonide as an inhibitor of stiffness-induced PDAC aggressiveness Co-author DOI 10.64898/2026.07.17.739125↗
  2. TGF-β1-mediated downregulation of L1CAM in pancreatic ductal adenocarcinoma drives upregulation of collagen 17A1 and MMP2, facilitating tumor invasiveness and … Co-author DOI 10.1038/s41419-025-07859-8↗
  3. Three-dimensional environment sensitizes pancreatic cancer cells to the anti-proliferative effect of budesonide by reprogramming energy metabolism. Last author DOI 10.1186/s13046-024-03072-1↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Enza Lonardo · 3 shared papers, 2024–2026 · strength 0.62
  2. Bruno Sáinz · 3 shared papers, 2024–2026 · strength 0.62
  3. Cristina D’Aniello · 2 shared papers, 2024–2026 · strength 0.43
  4. Eduardo Ibello · 2 shared papers, 2024–2026 · strength 0.43
  5. Donatella Delle Cave · 2 shared papers, 2024–2025 · strength 0.37
  6. Simone Mas · 1 shared paper, 2026 · strength 0.26
  7. Paolo A. Netti · 1 shared paper, 2026 · strength 0.26
  8. Alessandro Carrer · 1 shared paper, 2025 · strength 0.19

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.